Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis
Titel:
Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis
Auteur:
Feemster, John C. Westerland, Sarah M. Gossard, Thomas R. Steele, Tyler A. Timm, Paul C. Jagielski, Jack T. Strainis, Emma McCarter, Stuart J. Hopkins, Seth C. Koblan, Kenneth S. St. Louis, Erik K.